RNU6-473P

Across TCGA pan-cancer cohorts, RNU6-473P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-473P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-473P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-473P expression acts as an unfavorable survival marker.

BLCA and SKCM are the cancer types where RNU6-473P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.078	0.594	<.001	81	view →
SKCM	OS	Tertile	All	0.283	0.787	.014	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNU6-473P–BLCA (DFS)

Open the BLCA breakdown →